EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Metabolic Perspective on Atherosclerosis: Macrophage Reprogramming and Novel Therapeutic Targets

Zexun Wang iD, Ying Zhang iD, Lihua Li iD, Zhongqun Wang iD

Journal of the American Heart Association · 2026

DOI: 10.1161/jaha.125.047847 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of the American Heart Association, 2026. Verfasst von Zexun Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology Affiliated Hospital of Jiangsu University Zhenjiang China. Hauptthemen laut MEDLINE: Atherosclerosis, Energy Metabolism, Macrophages, Metabolic Reprogramming. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 149 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atherosclerosis is a chronic inflammatory disease driven by metabolic disorders, and macrophages play a central role in their occurrence and development. Macrophages are not static; their functional polarization and fate decisions are highly regulated by metabolic signals from the microenvironment, a process known as metabolic reprogramming. This review systematically reviews the latest progress in the metabolic reprogramming of glucose, lipids, and mitochondria in atherosclerosis, focusing on how key metabolites such as glycolysis, pentose phosphate pathway, cholesterol/sphingolipid metabolism, gut microbiota derivatives, and oxaloacetate dynamically regulate the inflammatory phenotype, foam cell formation, and immune response of macrophages. This review also delves into new concepts such as trained immunity and analyzes the therapeutic potential of targeting these metabolic pathways, aiming to comprehensively reveal the core role of metabolic‐immune cross‐talk in atherosclerosis and provide a theoretical basis for developing new strategies for diagnosing and treating atherosclerosis based on macrophage metabolic reprogramming.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AtherosclerosisEnergy MetabolismMacrophagesMetabolic ReprogrammingTrained ImmunityAnimalsHumansSignal Transduction

Stichwörter der Autor:innen

atherosclerosisgut microbiotaitaconatemacrophage metabolic reprogrammingtrained immunity

Autor:innen und Institutionen

  • Department of Cardiology Affiliated Hospital of Jiangsu University Zhenjiang China.
  • Institute of Cardiovascular Diseases Jiangsu University Zhenjiang China.
  • Department of Biochemistry and Molecular Biology Jiangsu University School of Medicine Zhenjiang China.
  • Department of Pathology Affiliated Hospital of Jiangsu University Zhenjiang China.

ORCID-Profile: Zexun Wang, Ying Zhang, Lihua Li, Zhongqun Wang

Zitieren

APA

Wang, Z., Zhang, Y., Li, L., & Wang, Z. (2026). Metabolic Perspective on Atherosclerosis: Macrophage Reprogramming and Novel Therapeutic Targets. Journal of the American Heart Association. https://doi.org/10.1161/jaha.125.047847

Vancouver

Wang Z, Zhang Y, Li L, Wang Z. Metabolic Perspective on Atherosclerosis: Macrophage Reprogramming and Novel Therapeutic Targets. Journal of the American Heart Association. 2026. doi:10.1161/jaha.125.047847

BibTeX
@article{Wang2026,
  author = {Wang, Zexun and Zhang, Ying and Li, Lihua and Wang, Zhongqun},
  title = {Metabolic Perspective on Atherosclerosis: Macrophage Reprogramming and Novel Therapeutic Targets},
  journal = {Journal of the American Heart Association},
  year = {2026},
  doi = {10.1161/jaha.125.047847}
}
Kostenlos starten →